Cargando…

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains

BACKGROUND: Analyses of brain samples from Alzheimer’s disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurano, Makoto, Saito, Yuko, Uranbileg, Baasanjav, Saigusa, Daisuke, Kano, Kuniyuki, Aoki, Junken, Yatomi, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780287/
https://www.ncbi.nlm.nih.gov/pubmed/36570536
http://dx.doi.org/10.3389/fnagi.2022.1066578
_version_ 1784856804355735552
author Kurano, Makoto
Saito, Yuko
Uranbileg, Baasanjav
Saigusa, Daisuke
Kano, Kuniyuki
Aoki, Junken
Yatomi, Yutaka
author_facet Kurano, Makoto
Saito, Yuko
Uranbileg, Baasanjav
Saigusa, Daisuke
Kano, Kuniyuki
Aoki, Junken
Yatomi, Yutaka
author_sort Kurano, Makoto
collection PubMed
description BACKGROUND: Analyses of brain samples from Alzheimer’s disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physiological actions and to be involved in the pathogenesis of various human diseases. In this cross-sectional study, we attempted to elucidate the associations of these bioactive lipids with the pathogenesis/pathology of AD through postmortem studies of human brains. METHODS: We measured the levels of glycerophospholipids, sphingolipids, and eicosanoids/related mediators in the brains of patients with AD (AD brains), patients with Cerad score B (Cerad-b brains), and control subjects (control brains), using a liquid chromatography-mass spectrometry method; we also measured the mRNA levels of specific receptors for these bioactive lipids in the same brain specimens. RESULTS: The levels of several species of sphingomyelins and ceramides were higher in the Cerad-b and AD brains. Levels of several species of lysophosphatidic acids (LPAs), lysophosphatidylcholine, lysophosphatidylserine, lysophosphatidylethanolamine (LPE), lysophosphatidylinositol, phosphatidylcholine, phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol, and phosphatidylglycerol were especially high in the Cerad-b brains, while those of lysophosphatidylglycerol (LPG) were especially high in the AD brains. Several eicosanoids, including metabolites of prostaglandin E2, oxylipins, metabolites of epoxide, and metabolites of DHA and EPA, such as resolvins, were also modulated in the AD brains. Among the lipid mediators, the levels of S1P2, S1P5, LPA1, LPA2, LPA6, P2Y10, GPR174, EP1, DP1, DP2, IP, FP, and TXA2r were lower in the AD and/or Cerad-b brains. The brain levels of ceramides, LPC, LPI, PE, and PS showed strong positive correlations with the Aβ contents, while those of LPG showed rather strong positive correlations with the presence of senile plaques and neurofibrillary tangles. A discriminant analysis revealed that LPG is especially important for AD and the LPE/PE axis is important for Cerad-b. CONCLUSIONS: Comprehensive lipidomics, together with the measurement of lipid receptor expression levels provided novel evidence for the associations of bioactive lipids with AD, which is expected to facilitate future translational research and reverse translational research.
format Online
Article
Text
id pubmed-9780287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97802872022-12-24 Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains Kurano, Makoto Saito, Yuko Uranbileg, Baasanjav Saigusa, Daisuke Kano, Kuniyuki Aoki, Junken Yatomi, Yutaka Front Aging Neurosci Aging Neuroscience BACKGROUND: Analyses of brain samples from Alzheimer’s disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physiological actions and to be involved in the pathogenesis of various human diseases. In this cross-sectional study, we attempted to elucidate the associations of these bioactive lipids with the pathogenesis/pathology of AD through postmortem studies of human brains. METHODS: We measured the levels of glycerophospholipids, sphingolipids, and eicosanoids/related mediators in the brains of patients with AD (AD brains), patients with Cerad score B (Cerad-b brains), and control subjects (control brains), using a liquid chromatography-mass spectrometry method; we also measured the mRNA levels of specific receptors for these bioactive lipids in the same brain specimens. RESULTS: The levels of several species of sphingomyelins and ceramides were higher in the Cerad-b and AD brains. Levels of several species of lysophosphatidic acids (LPAs), lysophosphatidylcholine, lysophosphatidylserine, lysophosphatidylethanolamine (LPE), lysophosphatidylinositol, phosphatidylcholine, phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol, and phosphatidylglycerol were especially high in the Cerad-b brains, while those of lysophosphatidylglycerol (LPG) were especially high in the AD brains. Several eicosanoids, including metabolites of prostaglandin E2, oxylipins, metabolites of epoxide, and metabolites of DHA and EPA, such as resolvins, were also modulated in the AD brains. Among the lipid mediators, the levels of S1P2, S1P5, LPA1, LPA2, LPA6, P2Y10, GPR174, EP1, DP1, DP2, IP, FP, and TXA2r were lower in the AD and/or Cerad-b brains. The brain levels of ceramides, LPC, LPI, PE, and PS showed strong positive correlations with the Aβ contents, while those of LPG showed rather strong positive correlations with the presence of senile plaques and neurofibrillary tangles. A discriminant analysis revealed that LPG is especially important for AD and the LPE/PE axis is important for Cerad-b. CONCLUSIONS: Comprehensive lipidomics, together with the measurement of lipid receptor expression levels provided novel evidence for the associations of bioactive lipids with AD, which is expected to facilitate future translational research and reverse translational research. Frontiers Media S.A. 2022-12-09 /pmc/articles/PMC9780287/ /pubmed/36570536 http://dx.doi.org/10.3389/fnagi.2022.1066578 Text en Copyright © 2022 Kurano, Saito, Uranbileg, Saigusa, Kano, Aoki and Yatomi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Aging Neuroscience
Kurano, Makoto
Saito, Yuko
Uranbileg, Baasanjav
Saigusa, Daisuke
Kano, Kuniyuki
Aoki, Junken
Yatomi, Yutaka
Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title_full Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title_fullStr Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title_full_unstemmed Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title_short Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
title_sort modulations of bioactive lipids and their receptors in postmortem alzheimer’s disease brains
topic Aging Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780287/
https://www.ncbi.nlm.nih.gov/pubmed/36570536
http://dx.doi.org/10.3389/fnagi.2022.1066578
work_keys_str_mv AT kuranomakoto modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT saitoyuko modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT uranbilegbaasanjav modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT saigusadaisuke modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT kanokuniyuki modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT aokijunken modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains
AT yatomiyutaka modulationsofbioactivelipidsandtheirreceptorsinpostmortemalzheimersdiseasebrains